FDA
featured
Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.
» Read More
More
-
NEW YORK, April 5- A federal judge on Friday ordered the U.S. Food and Drug Administration to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age and criticized the Obama administration for interfering with the process for political purposes.
-
NEW YORK, April 5- A federal judge on Friday ordered the U.S. Food and Drug Administration to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age and criticized the Obama administration for interfering with the process for political purposes.
-
CAMBRIDGE, Mass.-- InVivo Therapeutics Holdings Corp. said Friday that the Food and Drug Administration will allow it to start human trials of an experimental product that is intended to treat spinal cord injuries. The Cambridge, Mass., company said there are no FDA- approved treatments that intervene directly in the spinal cord following an injury.
-
NEW YORK, April 5- A federal judge on Friday ordered the U.S. Food and Drug Administration to make the "morning-after" emergency contraception pill available without a prescription to all girls of reproductive age.
-
NEW YORK, April 5- A federal judge on Friday ordered the U.S. Food and Drug Administration to make the "morning-after" emergency contraception pill available to girls of all ages without a prescription.
-
ATLANTA-- CryoLife Inc. said Thursday that the Food and Drug Administration cleared a new version of its HeRO graft. CryoLife said the new version of the graft has an adaptor that allows physicians to combine the HeRO with other dialysis access grafts. Shares of CryoLife rose 19 cents, or 3.2 percent, to $6.06 in afternoon trading.
-
Maine parents can make the right decisions for their families, "he said. Geoff Gratwick, D- Bangor, who's chief of rheumatology at Eastern Maine Medical Center. The Food and Drug Administration says exposure to UV radiation, whether from the sun or indoor tanning, can cause skin cancer, burns, premature skin aging and eye damage.
-
NEW YORK-- Shares of Navidea Biopharmaceuticals Inc. rose Thursday after the company reported favorable new clinical trial results for its imaging agent Lymphoseek. The Food and Drug Administration approved Lymphoseek March 13 to help doctors locate lymph nodes in patients with breast cancer and skin cancer.
-
Johnson & Johnson just won approval for a new diabetes drug, and the stock is at an all-time high today. Anthony Butler, Barclays, offers insight.
-
Shares of Repros Therapeutics Inc. shot up nearly 70 percent in premarket trading Thursday after the drug developer said its potential low testosterone treatment Androxal met both goals mandated by the Food and Drug Administration in a late-stage trial.
-
*Sales of Tecfidera expected to top $3 billion by 2017. WASHINGTON, March 27- U.S. regulators on Wednesday approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the No. 1 oral treatment for the disease, with annual sales topping $3 billion.
-
*Sales of Tecfidera expected to top $3 billion by 2017. WASHINGTON, March 27- U.S. regulators on Wednesday approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the No. 1 oral treatment for the disease, with annual sales topping $3 billion.
-
*Sales of Tecfidera expected to top $3 billion by 2017. March 27- U.S. regulators have approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the No. 1 oral treatment for the disease, with annual sales of more than $3 billion.
-
*Sales of Tecfidera expected to top $3 billion by 2017. March 27- U.S. regulators have approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the No. 1 oral treatment for the disease, with annual sales of more than $3 billion.
-
March 27- U.S. Food and Drug Administration:. *FDA says approved Biogen idec's tecfidera. capsules to treat adults with relapsing forms of Multiple Sclerosis.
-
Most big chain restaurants now put nutrition information on their menus. How accurate are these numbers? NBC News takes a closer look.
-
NEW YORK-- Shares of Pozen Inc. got a boost Wednesday after the company said it submitted a new drug application to the U.S. Food and Drug Administration for the marketing approval of two potential cardiovascular drugs. Pozen's drugs contain aspirin and the omeprazole, the active ingredient in heartburn drugs like Prilosec.
-
MOUNTAIN VIEW, Calif.-- Vivus Inc. said Tuesday that it has secured a $110 million financing arrangement with an investment fund to help promote its weight-loss drug Qsymia. The Food and Drug Administration approved Qsymia in July, and Vivus started selling the drug in September.
-
BOSTON, March 25- The U.S. crackdown on specialty pharmacies that compound drugs into customized doses on Monday yielded another recall after an inspection by the Food and Drug Administration.
-
BOSTON, March 25- The U.S. crackdown on specialty pharmacies that compound drugs into customized doses on Monday yielded another recall after an inspection by the Food and Drug Administration.